Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.13% | 0.44% | 8.41% | -11.35% | -2.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.13% | 0.44% | 8.41% | -11.35% | -2.29% |
| Cost of Revenue | -7.68% | -8.40% | -9.23% | -14.94% | -9.48% |
| Gross Profit | 37.02% | 5.00% | 18.02% | -9.15% | 2.21% |
| SG&A Expenses | 4.21% | 6.24% | 3.31% | -11.52% | -5.83% |
| Depreciation & Amortization | -78.54% | -91.53% | -60.00% | -34.18% | -10.20% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.33% | -8.48% | -5.83% | -14.56% | -7.11% |
| Operating Income | 53.58% | 26.36% | 32.17% | 19.57% | 14.30% |
| Income Before Tax | 52.24% | 30.94% | 29.16% | 16.91% | 6.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.24% | 30.94% | 29.16% | 16.91% | 6.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.24% | 30.94% | 29.16% | 16.91% | 6.12% |
| EBIT | 53.58% | 26.36% | 32.17% | 19.57% | 14.30% |
| EBITDA | 44.82% | -8.76% | 21.18% | 18.54% | 19.39% |
| EPS Basic | 53.06% | 31.91% | 30.61% | 17.31% | 7.55% |
| Normalized Basic EPS | 54.84% | 33.33% | 29.03% | 18.18% | 6.06% |
| EPS Diluted | 53.06% | 31.91% | 30.61% | 17.31% | 7.55% |
| Normalized Diluted EPS | 54.84% | 33.33% | 29.03% | 18.18% | 6.06% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |